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  A regioselective synthesis of ethyl 6-aryl-3-propylpyridazine-4-carboxylates by one-pot three-
component reaction of ethyl butyrylacetate with various arylglyoxals in the presence of 
hydrazine hydrate at room temperature in water was described. 
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1.  Introduction 
 
          Chemical  processes  that  allow  assembly  of  several building blocks in a single operation are 
gaining increasing attention in the search for new efficient, diversity-oriented synthetic 
methodologies, and particularly those directed toward heterocyclic compounds. Such processes are 
highly desirable for the rapid generation of libraries of small drug-like molecules for high-throughput 
screaning.
1-6 The design of multicomponent syntheses often relies on the integration of multiple 
individual reactions to give a one-pot synthetic operation, a new concept with important economical 
and environmental issues.
7-10 
 
    The chemistry and pharmacology of pyridazine derivatives have recently received considerable 
interest. This can be realized from the vast number of articles and patents published in the synthesis,   116
chemistry, and biological activities of pyridazines.
11-14 The pyridazines and their derivatives exhibit a 
broad range of biological activity, such as analgesic,
15 antibacterial,
16 anti-inﬂammatory,
11 
antihypertensive
17 or antihistaminic
18 properties. The derivatives of pyridazines could also find 
application as ligands in metallic complexes which possess catalytic properties.
19,20 These compounds 
could also be used as semi-conductor materials and as materials with non-linear optical properties.
21 
These pharmacological and technological properties of pyridazines encourage the development of 
methods for their synthesis and functionalization. In continuation of our interest in the synthesis of 
various pyridazine derivatives,
22-26 we decided to investigate the three-component reaction of 
arylglyoxals, ethyl butyrylacetate and hydrazine hydrate which is extended to the regioselective 
synthesis of ethyl 6-aryl-3-propylpyridazine-4-carboxylates as a new series of three substituted 
pyridazines. 
 
2. Results and Discussion 
    Similar to our latest researches describing the synthesis of pyridazine derivatives,
22-26 firstly the 
arylglyoxals (1-6) were produced from the corresponding acetophenones via oxidation with SeO2 in 
dioxane at reflux conditions.
27 Then the reaction of arylglyoxals (1-6) with ethyl butyrylacetate (7) in 
the presence of hydrazine hydrate at room temperature in water leds to form the ethyl 6-aryl-3-
propylpyridazine-4-carboxylates (8-14) in good yields as shown in the Scheme 1.  
 
 
Scheme 1: Synthesis of ethyl 6-aryl-3-propylpyridazine-4-carboxylates 
 
        All of the obtained products were listed at the Table 1. Formation of the 6-aryl substituted 
pyridazines as sole products proves this fact that the outlined strategy acts regioselectively and there 
is no evidence for production of 5-aryl substituted isomers. The mechanism of the regioselective 
synthesis of the products was shown in Scheme 2.  
    Owing to the high reactivity of the external carbonyl in comparison with internal carbonyl in an 
arylglyoxal system, the reaction was run through the nucleophilic attack of enol (15) to the aldehyde 
carbonyl of arylglyoxal (6) leading to form the intermediate (16) as a sole product. The subsequent 
condensation of hydrazine with the carbonyl groups of the intermediate (16) gives the final product 
(13).  
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Table 1. List of pyridazine products. 
Entry Pyridazine  Yield (%) 
1 
N
N
O O
8
75 
2 
N
N
O O
Br
9
88 
3 
N
N
O O
Cl
10
84 
4 
N
N
O O
F 11
81 
5 
N
N
O O
O2N
12
90 
6 
N
N
O O
H3CO
H3CO
13
80 
7  N
N
O O
O
O 14
79   118
H
O
O
O
O
O
N
N
O O
+
6
2
13    sole product
OCH3
H3CO
OH
O
O
15
O
O
O O
NH2NH2
16
-2 H2O
OCH3
H3CO
-H2O
H3CO
OCH3
O
O
O O
H
H3CO
H3CO
path A
path B
path A
path B
17 not formed
N
N
O O
H
H3CO
H3CO
18  not formed
H
 
Scheme 3: Suggested mechanism for regioselective synthesis of ethyl 6-(3,4-dimethoxyphenyl)-3-
propylpyridazine-4-carboxylate 
 
3. Conclusions  
 
    We have synthesized some new three substituted pyridazines via one-pot three component reaction 
of arylglyoxals, ethyl butyrylacetate and hydrazine hydrate in water at room temperature. The simple 
operation, the high regioselectivity and the convenient reaction condition of this procedure makes it a 
valuable route to prepare new substituted pyridazines. 
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Experimental 
 
General Procedures 
 
Elemental analyses for C, H and N were performed using Heraeus Leco analyzer 932. NMR spectra 
were recorded on a Bruker Avance spectrometer operating at 300 MHz for 
1H nuclei and 75.5 MHz 
for 
13C nuclei with tetramethylsilane as internal standard. Mass spectra were recorded using a Varian J. Khalafy et al.  / Current Chemistry Letters 1 (2012) 
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Matt 311 spectrometer operating at nominal accelerating voltage of 70 eV. Thin layer 
chromatography (TLC) was run on silica percolated aluminium plates (Merck Kieselgel F254). 
Melting points were determined on a Kofler hot-stage apparatus. 
 
Sample procedure for pyridazine synthesis. 
To a mixture of ethyl butyrylacetate (1 mmol) and arylglyoxal
27 (1 mmol) in water (5 mL), was 
successively added hydrazine hydrate (5 mmol) at room temperature; the resultant mixture was stirred 
for 20-35 min during which time a precipitate was formed. The precipitate was then filtered and 
washed with excess water. The crude product was purified by recrystallization from ethanol. 
 
Ethyl 6-phenyl-3-propylpyridazine-4-carboxylate (8): yellow crystals, 75%, mp 50-51 ºC.  
FT-IR (KBr) νmax: 3064, 2958, 2868, 1725, 1648, 1582, 1451, 1394, 1240, 1093, 755, 690 cm
-1. 
1H-
NMR (300 MHz, CDCl3) δ (ppm): 8.27 (s, 1H, Ar), 8.10-8.16 (m, 2H, Ar), 7.50-7.58 (m, 3H, Ar), 
4.49 (q, J 7.2 Hz, 2H, CH2), 3.41 (t, J 7.2 Hz, 2H, CH2), 1.87 (sex, J 7.2 Hz, 2H, CH2), 1.47 (t, J 7.2 
Hz, 3H, CH3), 1.08 (t, J 7.2 Hz, 3H, CH3). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 164.07, 160.38, 
158.79, 134.02, 132.67, 131.18, 129.32, 127.19, 126.73, 62.96, 34.82, 23.48, 14.13, 14.05. Anal. 
Calcd for C16H18N2O2, C 71.09, H 6.71, N 10.36; Found: C, 71.13; H, 6.66; N, 10.50. Mass spectrum 
m/z (%): 270 ([M
+], 18), 242 (100), 241 (82), 213 (36), 197 (37), 170 (88). 
 
Ethyl 6-(4-bromophenyl)-3-propylpyridazine-4-carboxylate (9): yellow crystals, 88%, mp 66-68 ºC. 
FT-IR (KBr) νmax: 3070, 2959, 2935, 2872, 1706, 1597, 1505, 1404, 1388, 1223, 1156, 851, 574 cm
-1. 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.25 (s, 1H, Ar), 8.02 (d, J 8.1 Hz, 2H, Ar), 7.68 (d, J 8.1 Hz, 
2H, Ar), 4.49 (q, J 7.2 Hz, 2H, CH2), 3.41 (t, J 7.2 Hz, 2H, CH2), 1.86 (sex, J 7.2 Hz, 2H, CH2), 1.46 
(t, J 7.2 Hz, 3H, CH3), 1.07 (t, J 7.2 Hz, 3H, CH3). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 164.71, 
160.63, 157.41, 133.78, 132.43, 130.01, 128.49, 125.46, 124.84, 62.74, 35.76, 23.30, 14.17, 14.09. 
Anal. Calcd for C16H17BrN2O2, C 55.03, H 4.91, N 8.02; Found: C, 55.05; H, 4.99; N, 8.11.  
 
Ethyl 6-(4-chlorophenyl)-3-propylpyridazine-4-carboxylate (10): yellow crystals, 84%, mp 69-70 ºC. 
FT-IR (KBr) νmax: 3068, 2963, 2931, 2871, 1734, 1594, 1414, 1385, 1238, 1095, 1010, 850, 756 cm
-1. 
1H NMR (300 MHz, CDCl3) δ (ppm): 8.16 (s, 1H, Ar), 8.07 (d, J 8.4 Hz, 2H, Ar), 7.51 (d, J 8.4 Hz, 
2H, Ar), 4.47 (q, J 7.2 Hz, 2H, CH2), 3.35 (t, J 7.2, 2H, CH2), 1.85 (sex, J 7.2 Hz, 2H, CH2), 1.45, (t, J 
7.2 Hz, 3H, CH3), 1.05 (t, J 7.2 Hz, 3H, CH3). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 165.24, 160.50, 
157.06, 136.63, 133.90, 129.34, 129.15, 128.15, 123.72, 62.48, 36.25, 23.15, 14.16, 14.08. Anal. 
Calcd for C16H17ClN2O2, C 63.05, H 5.62, N 9.19; Found: C, 63.00; H, 5.56; N, 9.20. Mass spectrum 
m/z (%): 306 ([M
++2], 3), 304 ([M
+], 10), 276 (100), 247 (42), 231 (40), 206 (32), 204 (89), 152 (19), 
139 (46), 75 (20). 
 
Ethyl 6-(4-fluorophenyl)-3-propylpyridazine-4-carboxylate (11): pale yellow crystals, 81%, mp 
42-43 ºC. 
FT-IR (KBr) νmax: 3055, 2963, 2873, 1716, 1602, 1509, 1389, 1254, 1163, 1094, 845, 757, 552 cm
-1. 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.16 (s, 1H, Ar), 8.08-8.15 (m, 2H, Ar), 7.18-7.27 (m, 2H, Ar), 
4.48 (q, J 7.2 Hz, 2H, CH2), 3.36 (t, J 7.2, 2H, CH2), 1.86 (sex, J 7.2 Hz, 2H, CH2), 1.47 (t, J 7.2 Hz, 
3H, CH3), 1.08 (t, J 7.2 Hz, 3H, CH3). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 165.92, 165.30, 162.60, 
160.21, 157.15, 131.60, 128.92, 128.81, 123.68, 116.30, 116.01, 62.44, 36.21, 23.14, 14.14, 14.07. 
Anal. Calcd for C16H17FN2O2, C, 66.65, H 5.94, N 9.72; Found: C, 65.72; H, 5.90; N, 9.85. Mass 
spectrum m/z (%): 288 ([M
+], 38), 260 (100), 231 (37), 215 (45), 188 (90), 157 (13), 120 (29). 
  
Ethyl 6-(4-nitrophenyl)-3-propylpyridazine-4-carboxylate (12): orange crystals, 90%, mp 118 ºC. 
FT-IR (KBr) νmax: 3078, 2965, 2931, 2872, 1733, 1601, 1514, 1394, 1346, 1305, 1242, 1093, 1019, 
857, 753, 694 cm
-1. 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.41 (d, J 8.7 Hz, 2H, Ar), 8.33 (d, J 8.7 
Hz, 2H, Ar), 8.27 (s, 1H, Ar), 4.50 (q, J 7.2 Hz, 2H, CH2), 3.40 (t, J 7.2 Hz, 2H, CH2), 1.87 (sex, J 7.2   120
Hz, 2H, CH2), 1.48 (t, J 7.2 Hz, 3H, CH3), 1.08 (t, J 7.2, 3H, CH3). 
13C-NMR (75 MHz, CDCl3) δ 
(ppm): 164.83, 161.56, 156.14, 149.06, 141.26, 129.49, 127.84, 124.54, 124.30, 62.74, 36.21, 23.19, 
14.15, 14.05. Anal. Calcd for C16H17N3O4, C 60.94, H 5.43, N 13.33; Found: C, 60.92; H, 5.39; N, 
13.43. Mass spectrum m/z (%): 315 ([M
+], 7), 287 (93), 258 (59), 242 (44), 215 (100), 152 (27), 139 
(28), 115 (19), 75 (18). 
 
Ethyl 6-(3,4-dimethoxyphenyl)-3-propylpyridazine-4-carboxylate (13): yellow crystals, 80%, mp 
64-65 ºC. 
FT-IR (KBr) νmax: 3087, 2958, 2935, 2873, 2835, 1716, 1590, 1516, 1465, 1399, 1261, 1222, 1149, 
1095, 1020, 872, 762 cm
-1. 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.26 (s, 1H, Ar), 7.93 (s, 1H, Ar), 
7.57 (d, J 8.1 Hz, 1H, Ar), 7.01 (d, J 8.1 Hz, 1H, Ar), 4.50 (q, J 7.2 Hz, 2H, CH2), 4.01 (s, 3H, 
OCH3), 3.97 (s, 3H, OCH3), 3.39 (t, J 7.2, 2H, CH2), 1.87 (sex, J 7.2 Hz, 2H, CH2), 1.47 (t, J 7.2 Hz, 
3H, CH3), 1.07 (t, J 7.2, 3H, CH3). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 163.57, 159.80, 158.27, 
152.40, 150.01, 132.21, 127.72, 125.56, 120.55, 111.22, 109.88, 63.24, 56.37, 56.11, 34.22, 23.49, 
14.14, 14.02. Anal. Calcd for C18H22N2O4, C 65.44, H 6.71, N 8.48; Found: C, 65.37; H, 6.68; N, 
8.57. Mass spectrum m/z (%): 330 ([M
+], 26), 302 (100), 301 (55), 273 (24), 257 (25), 230 (82), 204 
(24), 165 (32). 
 
Ethyl 6-(benzo[d][1,3]dioxol-5-yl)-3-propylpyridazine-4-carboxylate (14): yellow crystals, 79%, 
mp 89-90 ºC. 
FT-IR (KBr) νmax: 3083, 2961, 2928, 1725, 1499, 1446, 1402, 1254, 1036, 875 cm
-1. 
1H-NMR (300 
MHz, CDCl3) δ (ppm): 8.20 (s, 1H, Ar), 7.71 (s, 1H, Ar), 7.62 (d, J 7.8 Hz, 1H, Ar), 6.96 (d, J 7.8 Hz, 
1H, Ar), 6.08 (s, 2H, CH2), 4.49 (q, J 7.2 Hz, 2H, CH2), 3.40 (t, J 7.2, 2H, CH2), 1.84 (sex, J 7.2 Hz, 
2H, CH2), 1.46 (t, J 7.2 Hz, 3H, CH3), 1.07 (t, J 7.2, 3H, CH3). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 
164.86, 159.84, 158.17, 151.85, 149.02, 133.07, 131.53, 127.21, 122.14, 108.95, 107.28, 101.93, 
63.11, 34.43, 23.48, 14.15, 14.06. Anal. Calcd for C17H18N2O4, C 64.96, H 5.77, N 8.91; Found: C, 
64.90; H, 5.75; N, 8.86. 
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